Eli Lilly cuts annual profit forecast on stronger dollar
(Reuters) – Drugmaker Eli Lilly and Co cut its full-year profit forecast on Tuesday, as a stronger dollar piled more pressure on the drugmaker struggling with lower insulin prices and generic competition for its cancer drug.